Israeli pharmaceutical giant Teva has announced that the American Food and Drugs Administration (FDA) has granted approval for Synribo, an injectable drug for treating leukemia. The company says that the drug will soon be available for prescription.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments